Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP395404.RARdseCOO-o_2LPFUBhZD46DP4VeaviytiJG3jzLywlCU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP395404.RARdseCOO-o_2LPFUBhZD46DP4VeaviytiJG3jzLywlCU130_assertion type Assertion NP395404.RARdseCOO-o_2LPFUBhZD46DP4VeaviytiJG3jzLywlCU130_head.
- NP395404.RARdseCOO-o_2LPFUBhZD46DP4VeaviytiJG3jzLywlCU130_assertion description "[FAS surface expression on DN T cells should be assessed routinely and FAS haploinsufficient patients should be followed as its potential for lymphomagenesis is not well defined and a second hit might occur later on.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP395404.RARdseCOO-o_2LPFUBhZD46DP4VeaviytiJG3jzLywlCU130_provenance.
- NP395404.RARdseCOO-o_2LPFUBhZD46DP4VeaviytiJG3jzLywlCU130_assertion evidence source_evidence_literature NP395404.RARdseCOO-o_2LPFUBhZD46DP4VeaviytiJG3jzLywlCU130_provenance.
- NP395404.RARdseCOO-o_2LPFUBhZD46DP4VeaviytiJG3jzLywlCU130_assertion SIO_000772 23524443 NP395404.RARdseCOO-o_2LPFUBhZD46DP4VeaviytiJG3jzLywlCU130_provenance.
- NP395404.RARdseCOO-o_2LPFUBhZD46DP4VeaviytiJG3jzLywlCU130_assertion wasDerivedFrom befree-20150227 NP395404.RARdseCOO-o_2LPFUBhZD46DP4VeaviytiJG3jzLywlCU130_provenance.
- NP395404.RARdseCOO-o_2LPFUBhZD46DP4VeaviytiJG3jzLywlCU130_assertion wasGeneratedBy ECO_0000203 NP395404.RARdseCOO-o_2LPFUBhZD46DP4VeaviytiJG3jzLywlCU130_provenance.